Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T7MJ
|
|||
| Former ID |
DIB014363
|
|||
| Drug Name |
PF-06412562
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Phase 1 | [1] | |
| Company |
Pfizer
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02418819) A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Schizophrenic Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.